METTL3-mediated m6A modification of FUNDC1/IP3R2 pathway facilitates cardiac hypertrophy in obesity hypertension
Life Sciences · 2025
DOI: 10.1016/j.lfs.2025.123780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Sciences, 2025. Verfasst von Yulong Ma und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicin…. Hauptthemen laut MEDLINE: Inositol 1,4,5-Trisphosphate Receptors, Cardiomegaly, Hypertension, Methyltransferases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shanghai Municipal Health Commission.
Abstract (Originalsprache)
BACKGROUND: FUNDC1-mediated mitochondria-associated endoplasmic reticulum membrane (MAM) Ca2+ conduction is crucial in cardiac hypertrophy. N6-methyladenosine (m6A) methylation, a crucial mRNA modification, is implicated in this process. We hypothesise that m6A regulation of FUNDC1-mediated MAM-associated Ca2+ overload contributes to obesity hypertension (OBH) cardiac hypertrophy. METHODS: We investigated OBH in spontaneously hypertensive rats fed a high-fat diet, with WKY rats as controls. Assessments included blood pressure, cardiac hypertrophy, pyroptosis, protein expression of MAM-related (FUNDC1, IP3R2) and m6A-related gene (METTL3, IGF2BP2). MeRIP assay detected m6A methylation in mRNA. We also examined cardiomyocyte morphology, viability, mitochondrial function (mtROS, SOD, MDA and ATP levels), and expression of pyroptosis-related factors (IL-1β, IL-18, NLRP3, GSDMD-N and Caspase-1/p10) in vitro. Silencing and overexpression of FUNDC1 and METTL3 clarified MAM effects on cardiac hypertrophy. FUNDC1 and IP3R2 interaction was assessed by co-immunoprecipitation. RESULTS: OBH rats exhibited significantly elevated blood pressure, cardiac hypertrophy, MAM dysfunction, elevated FUNDC1, IP3R2 and METTL3 expression, and pyroptosis. Ang II treatment in vitro upregulated FUNDC1, causing mitochondrial dysfunction, inflammation and pyroptosis in cardiomyocytes. FUNDC1 knockdown improved cardiomyocyte morphology and function, reduced mitochondrial Ca2+ concentration, enhanced mitochondrial function and attenuated pyroptosis while increasing IP3R2 ubiquitination. Mito Tempo reversed cardiomyocyte hypertrophy, mitochondrial dysfunction, inflammatory response and pyroptosis induced by FUNDC1 overexpression. Additionally silencing METTL3 and IGF2BP2 reduced m6A methylation of FUNDC1, inhibiting its expression. CONCLUSION: METTL3 regulates FUNDC1 m6A methylation modification via IGF2BP2, thereby affecting FUNDC1 expression. FUNDC1 binding to IP3R2 regulates MAM-associated Ca2+ overload, inducing mitochondrial dysfunction and pyroptosis, leading to cardiac hypertrophy in OBH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
- Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: fudeyu@shutcm.edu.cn.
- Department of Cardiology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: yy2608@shutcm.edu.cn.
Förderung
- National Natural Science Foundation of China
- Shanghai Municipal Health Commission
Zitieren
APA
Ma, Y., Li, D., Zhou, X., Chen, X., Hou, C., Li, Y., Zhao, Y., Gui, M., Yao, L., Li, J., Wang, M., Fu, D., & Lu, B. (2025). METTL3-mediated m6A modification of FUNDC1/IP3R2 pathway facilitates cardiac hypertrophy in obesity hypertension. Life Sciences. https://doi.org/10.1016/j.lfs.2025.123780
Vancouver
Ma Y, Li D, Zhou X, Chen X, Hou C, Li Y, et al. METTL3-mediated m6A modification of FUNDC1/IP3R2 pathway facilitates cardiac hypertrophy in obesity hypertension. Life Sciences. 2025. doi:10.1016/j.lfs.2025.123780
BibTeX
@article{Ma2025,
author = {Ma, Yulong and Li, Da and Zhou, Xunjie and Chen, Xiaozhe and Hou, Chunlei and Li, Yunfeng and Zhao, Yuxiu and Gui, Mingtai and Yao, Lei and Li, Jianhua and Wang, Mingzhu and Fu, Deyu and Lu, Bo},
title = {METTL3-mediated m6A modification of FUNDC1/IP3R2 pathway facilitates cardiac hypertrophy in obesity hypertension},
journal = {Life Sciences},
year = {2025},
doi = {10.1016/j.lfs.2025.123780}
}
EUVIMED